Frontlight ResearchEarly access
Trial site
Jiangsu Cancer Institute & Hospital
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Childhood cancers2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Jiangsu Cancer Institute & Hospital3 trials
- Shanghai Chest Hospital2 trials
- Sun Yat-sen University2 trials
- Celcuity Inc1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Recruiting
Recruiting
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
Active, not recruiting
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
Active, not recruiting
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Childhood cancers2 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026